Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Federal Trade Commission
Cipla
Queensland Health
Merck

Generated: September 15, 2019

DrugPatentWatch Database Preview

Patent: 9,821,043

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,821,043
Title:Anti-HER2 vaccine based upon AAV derived multimeric structures
Abstract: The present invention relates to parvovirus mutated structural proteins comprising insertions of mimotopes of a HER2, compositions, multimeric structures, medicaments and vaccines comprising the same, nucleic acids, expression cassettes, constructs, vectors and cells comprising the nucleic acids, methods of preparing the structural proteins and methods of inducing a B-cell response or of treating a HER2-related disease.
Inventor(s): Michaelis; Uwe (Weilheim, DE), Jensen-Jarolim; Erika (Vienna, AT), Rehfuess; Christoph (Munchen, DE), Weghofer; Margit (Vienna, AT)
Assignee: Medigene AG (Planegg-Martinsried, DE)
Application Number:14/344,783
Patent Claims:see list of patent claims

Details for Patent 9,821,043

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Medigene AG (Planegg-Martinsried, DE) 2031-09-15 RX Orphan search
Genentech PERJETA pertuzumab VIAL; SINGLE-USE 125409 001 2012-06-08 ➤ Sign Up Medigene AG (Planegg-Martinsried, DE) 2031-09-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Boehringer Ingelheim
Covington
Moodys
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.